title: The Protective Effect of Icariin on Mitochondrial Transport and Distribution in Primary Hippocampal Neurons from 3× Tg-AD Mice.
abstract: Icariin, a pharmacologically active component isolated from the Chinese herb Epimedium, has been shown to improve spatial learning and memory abilities in Alzheimer's disease (AD) rats through inhibition of Aβ production and tau protein hyperphosphorylation. However, the potential mechanism of icariin-induced protective effects against mitochondrial dysfunctions in AD still remains unclear. In the present study, we investigated the effect of icariin on the modulation of mitochondrial transport and distribution in primary hippocampal cultures from triple-transgenic (3× Tg) AD mice. The results showed that icariin enhanced mitochondrial motility and increased mitochondrial index and mitochondrial length and size in the diseased neurons. Additionally, the expression of the key mitochondrial enzyme, pyruvate dehydrogenase-E1α (PDHE1α), and the post synaptic density protein 95 (PSD95), was preserved in AD neurons after icariin treatment, accompanied by a downregulation of Aβ and phosphorylated tau expression in the corresponding areas. Further study showed that icariin treatment resulted in a decrease in mitochondrial fission protein dynamin-related protein 1 (Drp1) and an increase in fusion protein Mitofusin 2 (Mfn2). These data indicate that icariin can promote mitochondrial transport, protect mitochondria against fragmentation and preserve the expression of mitochondrial and synaptic functional proteins in AD neurons. Thus, icariin may be a potential therapeutic complement for AD and other mitochondrial malfunction-related neuronal degenerative diseases.
authors.affiliation: College of Life Science, Shenzhen Key Laboratory of Marine Bioresources and Ecology, Shenzhen University, Shenzhen 518060, China. lilyq335@126.com.
authors.forename: Yijing
authors.initials: Y
authors.lastname: Chen
authors.affiliation: College of Life Science, Shenzhen Key Laboratory of Marine Bioresources and Ecology, Shenzhen University, Shenzhen 518060, China. shuangxuehan2012@163.com.
authors.forename: Shuangxue
authors.initials: S
authors.lastname: Han
authors.affiliation: College of Life Science, Shenzhen Key Laboratory of Microbial Genetic Engineering, Shenzhen University, Shenzhen 518060, China. huangxx@siat.ac.cn.
authors.forename: Xiuxian
authors.initials: X
authors.lastname: Huang
authors.affiliation: College of Life Science, Shenzhen Key Laboratory of Marine Bioresources and Ecology, Shenzhen University, Shenzhen 518060, China. jzni@szu.edu.cn.
authors.forename: Jiazuan
authors.initials: J
authors.lastname: Ni
authors.affiliation: College of Life Science, Shenzhen Key Laboratory of Marine Bioresources and Ecology, Shenzhen University, Shenzhen 518060, China. hexy2008@szu.edu.cn.
authors.forename: Xiaoyang
authors.initials: X
authors.lastname: He
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy* / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002478:Cells, Cultured; D002642:Chick Embryo; D004195:Disease Models, Animal; D005419:Flavonoids / Q000008:administration & dosage* / Q000494:pharmacology; D006624:Hippocampus / Q000166:cytology*; D051379:Mice; D008928:Mitochondria / Q000187:drug effects* / Q000378:metabolism; D063154:Mitochondrial Dynamics / Q000187:drug effects; D053142:Mitochondrial Size / Q000187:drug effects; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D016875:tau Proteins / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D005419:Flavonoids; D016875:tau Proteins; C056599:icariin
keywords: Alzheimer’s disease; icariin; mitochondrial dysfunction; mitochondrial transport
references.citation: Ann N Y Acad Sci. 2000 Apr;903:204-21
references.pmid: 10818509
references.citation: J Alzheimers Dis. 2010;20 Suppl 2:S609-31
references.pmid: 20463406
references.citation: Am J Psychiatry. 2001 Feb;158(2):227-33
references.pmid: 11156805
references.citation: Physiol Rev. 2001 Apr;81(2):741-66
references.pmid: 11274343
references.citation: JAMA. 2002 Nov 6;288(17):2123-9
references.pmid: 12413371
references.citation: Neuron. 2003 Jul 31;39(3):409-21
references.pmid: 12895417
references.citation: Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2173-8
references.pmid: 14769913
references.citation: Science. 2004 Apr 16;304(5669):448-52
references.pmid: 15087549
references.citation: Neurosci Lett. 1980 May 15;18(1):105-10
references.pmid: 6133246
references.citation: Neurology. 1998 Feb;50(2):368-73
references.pmid: 9484355
references.citation: FASEB J. 2005 Apr;19(6):597-8
references.pmid: 15665036
references.citation: Prog Neurobiol. 2007 Feb;81(2):89-131
references.pmid: 17275978
references.citation: Trends Mol Med. 2008 Feb;14(2):45-53
references.pmid: 18218341
references.citation: Nat Rev Neurosci. 2008 Jul;9(7):505-18
references.pmid: 18568013
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19318-23
references.pmid: 19050078
references.citation: J Biol Chem. 2009 Jul 10;284(28):18754-66
references.pmid: 19389700
references.citation: J Neurosci. 2009 Jul 15;29(28):9090-103
references.pmid: 19605646
references.citation: J Biol Chem. 2009 Jul 31;284(31):20909-16
references.pmid: 19491104
references.citation: Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14670-5
references.pmid: 19667196
references.citation: Eur J Pharmacol. 2010 Jan 25;626(2-3):213-8
references.pmid: 19782061
references.citation: Neurodegener Dis. 2010;7(1-3):56-9
references.pmid: 20160460
references.citation: Cell Mol Neurobiol. 2010 May;30(4):577-90
references.pmid: 19943189
references.citation: Neuropharmacology. 2010 Nov;59(6):542-50
references.pmid: 20708632
references.citation: Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18670-5
references.pmid: 20937894
references.citation: Phytother Res. 2010 Nov;24(11):1658-63
references.pmid: 21031624
references.citation: Biochim Biophys Acta. 2011 Apr;1812(4):507-13
references.pmid: 21241801
references.citation: J Neurosci. 2011 Mar 9;31(10):3926-34
references.pmid: 21389247
references.citation: J Ethnopharmacol. 2011 Apr 12;134(3):519-41
references.pmid: 21215308
references.citation: Brain Res Rev. 2011 Jun 24;67(1-2):103-18
references.pmid: 21145355
references.citation: J Neurosci. 2011 Jul 6;31(27):9858-68
references.pmid: 21734277
references.citation: Am J Pathol. 2011 Oct;179(4):2071-82
references.pmid: 21854751
references.citation: Nat Neurosci. 2012 Mar;15(3):349-57
references.pmid: 22286176
references.citation: J Neurosci. 2012 Feb 15;32(7):2430-41
references.pmid: 22396417
references.citation: J Neurosci. 2012 Apr 25;32(17):5953-63
references.pmid: 22539855
references.citation: Oxid Med Cell Longev. 2012;2012:843649
references.pmid: 22666521
references.citation: Food Chem Toxicol. 2012 Aug;50(8):2751-9
references.pmid: 22613215
references.citation: Mol Neurobiol. 2012 Aug;46(1):205-16
references.pmid: 22847631
references.citation: Neurobiol Dis. 2013 Mar;51:13-26
references.pmid: 22297163
references.citation: Neuroscience. 2013 Feb 12;231:345-52
references.pmid: 23232258
references.citation: J Neurosci. 2013 Oct 23;33(43):17042-51
references.pmid: 24155308
references.citation: Front Neuroendocrinol. 2014 Jan;35(1):8-30
references.pmid: 23994581
references.citation: Int J Biol Sci. 2014;10(2):181-91
references.pmid: 24550686
references.citation: Mutat Res Rev Mutat Res. 2014 Jan-Mar;759:1-13
references.pmid: 24055911
references.citation: Biochim Biophys Acta. 2014 Jul;1837(7):1069-74
references.pmid: 24561226
references.citation: Biochim Biophys Acta. 2014 Aug;1842(8):1258-66
references.pmid: 24051203
references.citation: CNS Neurosci Ther. 2016 Jan;22(1):63-73
references.pmid: 26584824
references.citation: J Alzheimers Dis. 2010;20 Suppl 2:S265-79
references.pmid: 20442494
references.citation: Science. 2000 Oct 27;290(5492):750-4
references.pmid: 11052931